BioSpace News Archive

Licensing agreement announced between Inoviq and ResearchDx to offer EXO-NET exosome isolation and diagnostic development services in the US

ResearchDx Inc (ResearchDx), a premier Contract Diagnostics Organization (CDO) offering complete in vitro diagnostic (IVD) services and INOVIQ Limited (INOVIQ)

September 15, 2023
·
1 min read
BioCapital

United Urology Group and Its Affiliate Practices and Prostate Centers USA® are collaborating to Revolutionizing Men’s Health Care with Minimally Invasive Solutions

United Urology Group and its Affiliate Practices and Prostate Centers USA® are pleased to announce a groundbreaking initiative in the treatment of Benign Prostatic Hyperplasia.

September 15, 2023
·
5 min read
Policy

FDA Roundup: September 15, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

September 15, 2023
·
7 min read
Genetown

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 15, 2023

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, announced that on September 5, 2023, Anika granted restricted stock units covering 10,000 shares of common stock to one newly hired non-executive employee.

September 15, 2023
·
1 min read
Business

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023

Integrated BioPharma, Inc. reports its financial results for the quarter and fiscal year ended June 30, 2023.

September 15, 2023
·
5 min read
Genetown

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 15, 2023

Fulcrum Therapeutics, Inc.®, a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced that the company granted non-statutory stock options to new employees.

September 15, 2023
·
1 min read